sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> biosimilars market

report

Biosimilars Market, by Product Types (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Applications (Oncology, Blood Disorders, Infectious Diseases, Autoimmune Diseases and Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC113 October 2016 102 FREE 10% CUSTOMIZATION

Global Biosimilars Market worth USD 3 billion in 2016 and expected to reach USD 58.40 billion by 2022, at a CAGR of 52.77% from 2016 to 2022.

Our industry experts anticipate that within the biosimilars market, the recombinant glycosylated proteins will be the fastest-growing product segment, growing at a CAGR ranging from 70% to 55%. In addition, oncology will be the largest and the fastest-growing application segment in the market, growing at a CAGR ranging from 80% to 55% by 2022.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the key factors is propelling the growth of the global market
  • Detailed analysis of the geographic region that will witness the strongest growth
  • Granular analysis of the current market scenario and the expected market grow

KEY PREMIUM INDUSTRY INSIGHTS

  • The biosimilars market offers many growth opportunities and driving factors as compared to the restraining factors. It is stated by various research scientists that development of biosimilars will drastically reduce the price of the pharmaceutical drugs.
  • A large number of key companies such as Hospira, Inc., Teva Pharmaceutical, Amgen, and others are in constant efforts to develop biosimilars and are rigorously increasing their research & development expenses on clinical trials to introduce novel biosimilars, driving the market growth.
  • Amgen, Inc. has a strong research pipeline (phase III molecule) for the biosimilar products, such as ABP 501, ABP 980, and ABP 215.
  • The demand for biosimilars is also expected to increase due to the rise in the incidences of the diseases such as cancer, cardiovascular diseases, and such others. For these diseases, biosimilars have proven a promising option for the disease diagnosis and mitigation.
  • Other factors such as rising number of off-patented drugs, positive result of many biosimilar clinical trials and others drive the market growth to a great extent.
  • However, a strict regulatory framework for the biosimilar manufacturers to develop these products restricts the companies from investing in this market, which in turn would hamper the market growth during the future period.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s biosimilars market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study

MARKET SEGMENTATION

This report analyzes the biosimilars market by the following segments:

  • Biosimilars Market, by Product Types
    • Recombinant Non-Glycosylated Proteins
    • Recombinant Glycosylated Proteins
    • Recombinant Peptides
  • Biosimilars Market, by Applications
    • Oncology
    • Blood Disorders
    • Infectious Diseases
    • Autoimmune Diseases
    • Others

KEY MARKET PLAYERS

Key players in the biosimilars market include:

  • Amgen Inc.
  • Astra Zeneca, Plc.
  • Biocon Ltd.
  • Pfizer, Inc.
  • Novartis International AG
  • STADA Arzneimittel AG
  • Teva Pharmaceutical Industries Ltd.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

Biosimilars Market

TRENDING RELATED REPORT

Synthetic Biology Market, by Product (Core Products and Enabling Products), Application (Chemical, Healthcare, and Agriculture), Technology (Genome Engineering, DNA Sequencing, Bioinformatics and Biological Components and Integration Systems) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. INTRODUCTION
  2. MARKET OVERVIEW
    1. Market Definition
    2. Research Methodology
    3. Market Segmentation
    4. Assumption
  3. EXECUTIVE SUMMARY
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Trends
  5. INDUSTRY ANALYSIS
    1. Industry Overview
    2. Regulatory Analysis
      1. European Medicines Agency (EMA)
      2. U.S. FDA
      3. India
      4. Latin America
      5. Other Asia-Pacific Countries
    3. Time to Entry Analysis
    4. Pipeline  Analysis
    5. Pricing Analysis
    6. Stakeholders Analysis
  6. BIOSIMILARS MARKET, BY PRODUCT TYPES
    1. Market Overview
    2. Market Share Segmentation
    3. Revenue Segmentation
    4. Product Types
      1. Recombinant Non-Glycosylated Proteins
      2. Recombinant Glycosylated Proteins
      3. Recombinant Peptides
  7. BIOSIMILARS MARKET, BY APPLICATIONS
    1. Market Overview
    2. Market Share Segmentation
    3. Revenue Segmentation
    4. Applications
      1. Oncology
      2. Blood Disorders
      3. Infectious Diseases
      4. Autoimmune Diseases
      5. Others
  8. BIOSIMILARS MARKET, BY GEOGRAPHY
    1. Geographic Overview
    2. Market Share Segmentation
    3. Revenue Segmentation
    4. Volume Segmentation
    5. North America
      1. By Regions
        1. U.S.
        2. Canada
      2. By Product Types
      3. By Applications
    6. Europe
      1. By Regions
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Rest of Europe
      2. By Product Types
      3. By Applications
    7. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Russia
        4. Australia
        5. Japan
        6. South Korea
        7. Rest of Asia-Pacific
      2. By Product Types
      3. By Applications
    8. Middle East & Africa
      1. By Regions
        1. Egypt
        2. South Africa
        3. Nigeria
        4. Rest of Middle East & Africa
      2. By Product Types
      3. By Applications
    9. Latin America
      1. By Regions
        1. Brazil
        2. Argentina
        3. Columbia
        4. Mexico
        5. Rest of Latin America
  9. COMPETITIVE LANDSCAPE
    1. Market Share Analysis
  10. KEY MARKET PLAYERS
    1. Amgen Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Astra Zeneca, Plc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Biocon Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Pfizer, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Novartis International AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. STADA Arzneimittel AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Teva Pharmaceutical Industries Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX

 

LIST OF TABLES

Table 1.                Research Methodology

Table 2.                Assumptions

Table 3.                Global Biosimilars Market Size (US$ billion), (2016-2022)

Table 4.                Global Biosimilars Volume (million units), (2014-2022)

Table 5.                EMA Approved Biosimilars

Table 6.                U.S. FDA Approved Biosimilars

Table 7.                Approved Biosimilars in India

Table 8.                Biosimilars Approved, Marketed in Latin America

Table 9.                Biosimilars Approved, Marketed in Australia

Table 10.              Time to Entry Analysis (Generics vs. Biologics vs. Biosimilars)

Table 11.              Time to Market Entry for Biosimilars from EMA’s approval

Table 12.              Top Selling Biologic Products to lose patent in the coming years (Sales in US$ Billion)

Table 13.              Companies with largest number of Biosimilars in Pipeline (2015)

Table 14.              Top Biosimilars in Phase 3 Stage of the Development

Table 15.              Development & Investment Costs (Generics vs. Biologics vs. Biosimilars)

Table 16.              Pricing of Top Biosimilars Products with Average Market Price (2015)

Table 17.              Impact of the Growth of Biosimilars Market on Stakeholders

Table 18.              Global Biosimilars Market Size (US$ billion), By Product Types (2014 – 2022)

Table 19.              Global Recombinant Glycosylated Proteins Biosimilars Market Size (US$ billion), By Regions (2014-2022)

Table 20.              Global Recombinant Non-Glycosylated Proteins Biosimilars Market Size (US$ billion),By Regions (2014-2022)

Table 21.              Global Recombinant Peptides Biosimilars Market Size (US$ billion), By Regions (2014-2022)

Table 22.              Global Biosimilars Market Size (US$ billion), By Applications (2014-2022)

Table 23.              Global Biosimilars Market for Oncology; Market Size (US$ billion) (2014-2022)

Table 24.              Global Biosimilars Market for Blood Disorders; Market Size (US$ billion) (2014-2022)

Table 25.              Global Biosimilars Market for Infectious Diseases; Market Size (US$ billion) (2014-2022)

Table 26.              Global Biosimilars Market for Autoimmune Diseases; Market Size (US$ billion) (2014-2022)

Table 27.              Global Biosimilars Market for Other Diseases; Market Size (US$ billion) (2014-2022)

Table 28.              Biosimilars Market Prospects, by Geography (2016-2022)

Table 29.              Global Biosimilars Market Size (US$ billion), By Regions (2014-2022)

Table 30.              Global Biosimilars Market; Market Size, By Major Countries (2014-2022)

Table 31.              Global Biosimilars Volume (million units), (2014-2022)

Table 32.              Biosimilars Market in North America; Market Size (US$ billion) (2014-2022)

Table 33.              Biosimilars Market in U.S; Market Size (US$ billion), (2014-2022)

Table 34.              Biosimilars Market in Canada; Market Size (US$ billion), (2014-2022)

Table 35.              Biosimilars Market in North America; Market Size (US$ billion), By Product Type (2014-2022)

Table 36.              Biosimilars Market in North America; Market Size (US$ billion), By Applications (2014-2022)

Table 37.              Biosimilars Market in Europe; Market Size (US$ billion)

Table 38.              Biosimilars Market in Germany; Market Size (US$ billion), (2014-2022)

Table 39.              Biosimilars Market in U.K; Market Size (US$ billion), (2014-2022)

Table 40.              Biosimilars Market in France; Market Size (US$ billion), (2014-2022)

Table 41.              Biosimilars Market in Italy; Market Size (US$ billion), (2014-2022)

Table 42.              Biosimilars Market in Rest of Europe; Market Size (US$ billion), (2014-2022)

Table 43.              Biosimilars Market in Europe; Market Size (US$ billion), By Product Type (2014-2022)

Table 44.              Biosimilars Market in Europe; Market Size (US$ billion), By Applications (2014-2022)

Table 45.              Biosimilars Market in Asia-Pacific; Market Size (US$ billion)

Table 46.              Biosimilars Market in China; Market Size (US$ billion), (2014-2022)

Table 47.              Biosimilars Market in India; Market Size (US$ billion), (2014-2022)

Table 48.              Biosimilars Market in Russia; Market Size (US$ billion), (2014-2022)

Table 49.              Biosimilars Market in Australia; Market Size (US$ billion), (2014-2022)

Table 50.              Biosimilars Market in Japan; Market Size (US$ billion), (2014-2022)

Table 51.              Biosimilars Market in South Korea; Market Size (US$ billion), (2014-2022)

Table 52.              Biosimilars Market in Rest of Asia-Pacific; Market Size (US$ billion), (2014-2022)

Table 53.              Biosimilars Market in Asia-Pacific; Market Size (US$ billion), By Product Type (2014-2022)

Table 54.              Biosimilars Market in Asia-Pacific; Market Size (US$ billion), By Applications (2014-2022)

Table 55.              Biosimilars Market in Middle East & Africa; Market Size (US$ billion)

Table 56.              Biosimilars Market in Egypt; Market Size (US$ billion), (2014-2022)

Table 57.              Biosimilars Market in South Africa; Market Size (US$ billion), (2014-2022)

Table 58.              Biosimilars Market in Nigeria; Market Size (US$ billion), (2014-2022)

Table 59.              Biosimilars Market in Rest of Middle East & Africa; Market Size (US$ billion), (2014-2022)

Table 60.              Biosimilars Market in Middle East & Africa; Market Size (US$ billion), By Product Type (2014-2022)

Table 61.              Biosimilars Market in Middle East & Africa; Market Size (US$ billion), By Applications (2014-2022)

Table 62.              Biosimilars Market in Latin America; Market Size (US$ billion)

Table 63.              Biosimilars Market in Brazil; Market Size (US$ billion), (2014-2022)

Table 64.              Biosimilars Market in Argentina; Market Size (US$ billion), (2014-2022)

Table 65.              Biosimilars Market in Columbia; Market Size (US$ billion), (2014-2022)

Table 66.              Biosimilars Market in Mexico; Market Size (US$ billion), (2014-2022)

Table 67.              Biosimilars Market in Rest of Latin America; Market Size (US$ billion), (2014-2022)

Table 68.              Biosimilars Market in Latin America; Market Size (US$ billion), By Product Type (2014-2022)

Table 69.              Biosimilars Market in Latin America; Market Size (US$ billion), By Applications (2014-2022)

Table 70.              Acronyms

 

LIST OF FIGURES

Figure 1.               Research Methodology

Figure 2.               Global Biosimilars Market Share (%), By Geography (2015 & 2022)

Figure 3.               Global Biosimilars Market Share(%), By Product Type (2015 & 2022)

Figure 4.               Global Biosimilars Market Share(%), By Applications (2015 & 2022)

Figure 5.               Biosimilars Timeline

Figure 6.               Market Attractiveness for Biosimilars Set-up

Figure 7.               Number of Biological Products going off-patent by 2022 in U.S.

Figure 8.               Estimated sales of Biological Products going off-patent by 2022 in U.S (in Billion)

Figure 9.               Biosimilars by Stage of Development (2016)

Figure 10.            Number (in percentage) of Biosimilar Companies By Geography (2016)

Figure 11.            Global Biosimilars Market: Prescriber Acceptance vs. Patient Acceptance, By Geography (2015)

Figure 12.            Market Attractiveness for different Biosimilars Product Segments

Figure 13.            Global Biosimilars Market By Product Segments: Market Size vs. Market Penetration (2015)

Figure 14.            Global Biosimilars Market Share (%), By Product Type (2015 & 2022)

Figure 15.            Global Biosimilars Market Size (US$ billion), By Product Types (2014-2022)

Figure 16.            Global Recombinant Glycosylated Proteins Biosimilars Market Size (US$ billion), By Regions (2015 & 2022)

Figure 17.            Global Recombinant Non-Glycosylated Proteins Biosimilars Market Size (US$ billion), By Regions (2015 & 2022)

Figure 18.            Global Recombinant Peptides Biosimilars Market Size (US$ billion), By Regions (2015 & 2022)

Figure 19.            Global Biosimilars Market Size (US$ billion), By Applications (2015)

Figure 20.            Global Biosimilars Market Share (%), By Applications (2015 & 2022)

Figure 21.            Global Biosimilars Market Size (US$ billion), By Applications (2015 vs. 2022)

Figure 22.            Global Biosimilars Market  for Oncology; Market Size (US$ billion) (2015 & 2022)

Figure 23.            Global Biosimilars Market  for Blood Disorders; Market Size (US$ billion) (2015 & 2022)

Figure 24.            Global Biosimilars Market for Infectious Diseases; Market Size (US$ billion) (2015 & 2022)

Figure 25.            Global Biosimilars Market for Autoimmune Diseases; Market Size (US$ billion) (2015 & 2022)

Figure 26.            Global Biosimilars Market for Other Diseases; Market Size (US$ billion) (2015 & 2022)

Figure 27.            Global Biosimilars Market Share (%), By Major Regions(2015 & 2022)

Figure 28.            Top 5 Countries, By Market Share (%) (2015)

Figure 29.            Top 5 Countries, By Market Share (%) (2022)

Figure 30.            Biosimilars Market in North America; Snapshot (2015)

Figure 31.            Biosimilars Market in North America; Market Size (US$ billion) (2014-2022)

Figure 32.            Biosimilars Market in North America; Market Size (US$ billion), By Product Type (2014-2022)

Figure 33.            Biosimilars Market in North America; Market Size (US$ billion), By Applications (2016 vs. 2022)

Figure 34.            Biosimilars Market in Europe; Snapshot (2015)

Figure 35.            Biosimilars Market in Europe; Market Size (US$ billion) (2014-2022)

Figure 36.            Biosimilars Market in Europe; Market Size (US$ billion), By Product Type (2014-2022)

Figure 37.            Biosimilars Market in Europe; Market Size (US$ billion), By Applications (2016 vs. 2022)

Figure 38.            Biosimilars Market in Asia-Pacific; Snapshot (2015)

Figure 39.            Biosimilars Market in Asia-Pacific; Market Size (US$ billion)(2014-2022)

Figure 40.            Biosimilars Market in Asia-Pacific; Market Size (US$ billion), By Product Type (2014-2022)

Figure 41.            Biosimilars Market in Asia-Pacific; Market Size (US$ billion), By Applications (2016 vs. 2022)

Figure 42.            Biosimilars Market in Middle East & Africa; Snapshot (2015)

Figure 43.            Biosimilars Market in Middle East & Africa; Market Size (US$ billion) (2014-2022)

Figure 44.            Biosimilars Market in Middle East & Africa; Market Size (US$ billion), By Product Segments(2014-2022)

Figure 45.            Biosimilars Market in Middle East & Africa; Market Size (US$ billion), By Applications (2016 vs. 2022)

Figure 46.            Biosimilars Market in Middle Latin America; Snapshot (2015)

Figure 47.            Biosimilars Market in Latin America; Market Size (US$ billion) (2014-2022)

Figure 48.            Biosimilars Market in Latin America; Market Size (US$ billion), By Product Type(2014-2022)

Figure 49.            Biosimilars Market in Latin America; Market Size (US$ billion), By Applications (2016 vs. 2022)

Figure 50.            Market Share (%) of Major Players (2015)

Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us